Cerebral Palsy Law Blog : Cerebral Palsy Lawyer & Attorney : Burke & Eisner Law Firm : Medical Malpractice Lawyers & Attorneys

Spasticity is a condition that affects some individuals with cerebral palsy, multiple sclerosis, and brain or spinal cord injury. Those who have spastic cerebral palsy experience impaired movement due to muscle stiffness, involuntary muscle spasms and limited range of motion in joints.

Dealing with any kind of physical impairment can be a challenge, and many people turn to community support groups or networks to share their stories, experiences, and advice. Online communities are especially popular, and one in particular seeks to empower and connect individuals with spasticity.

That community is called Exploring Spasticity and it invites anyone whose life is touched by spasticity – caregivers, children, adults, family members, and friends – to join. People are encouraged to share their stories, some of which are featured in an annual complimentary spasticity calendar.

The website also offers information on spasticity treatment as well as links to resources.






 


 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

The Food and Drug Administration issued a warning that Allergan's Botox and Botox Cosmetic as well as Solstice Neuroscience's Myobloc have been linked to adverse reactions including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses.

The agency said the reactions may be related to overdosing and were found in both FDA-approved and nonapproved usages, but there is no evidence that they're related to any defect in the products.

The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy, which isn't an FDA-approved use of botulism toxins in children or adults.

The agency is currently reviewing safety data from clinical studies submitted by the drugs' manufacturers, as well as post-marketing adverse event reports and medical literature.

• Email This
• Print
• Comments
• Trackbacks (1)
• Share Link